Microparticles: Key Protagonists in Cardiovascular Disorders

 

 Buy Article Permissions and Reprints

ABSTRACT

Microparticles (MP) are shed membrane vesicles released by various cell types following apoptosis or activation. MP circulate in human plasma and also accumulate in atherosclerotic lesions. A growing body of evidence has highlighted their involvement in inflammation, angiogenesis, coagulation, and the regulation of vascular tone. MP may therefore contribute to the initiation and development of atherosclerosis and its complications. Plasma MP originate from platelets, leukocytes, erythrocytes, and endothelial cells, and their levels increase in patients with cardiovascular diseases; specific cardiovascular medications also affect plasma MP levels. Most recent data suggest a potential prognostic role of circulating MP for identification of subjects prone to develop cardiovascular complications.

REFERENCES

• 1 Wolf P. The nature and significance of platelet products in human plasma.  Br J Haematol. 1967;  13(3) 269-288
  CrossrefPubMedGoogle Scholar
• 2 Boulanger C M, Amabile N, Tedgui A. Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease.  Hypertension. 2006;  48(2) 180-186
  CrossrefPubMedGoogle Scholar
• 3 Morel O, Toti F, Hugel B et al. Procoagulant microparticles: disrupting the vascular homeostasis equation?.  Arterioscler Thromb Vasc Biol. 2006;  26(12) 2594-2604
  CrossrefPubMedGoogle Scholar
• 4 Huber J, Vales A, Mitulovic G et al. Oxidized membrane vesicles and blebs from apoptotic cells contain biologically active oxidized phospholipids that induce monocyte-endothelial interactions.  Arterioscler Thromb Vasc Biol. 2002;  22(1) 101-107
  CrossrefPubMedGoogle Scholar
• 5 Kolowos W, Gaipl U S, Sheriff A et al. Microparticles shed from different antigen-presenting cells display an individual pattern of surface molecules and a distinct potential of allogeneic T-cell activation.  Scand J Immunol. 2005;  61(3) 226-233
  CrossrefPubMedGoogle Scholar
• 6 Miguet L, Pacaud K, Felden C et al. Proteomic analysis of malignant lymphocyte membrane microparticles using double ionization coverage optimization.  Proteomics. 2006;  6(1) 153-171
  CrossrefPubMedGoogle Scholar
• 7 Bernimoulin M, Waters E K, Foy M et al. Differential stimulation of monocytic cells results in distinct populations of microparticles.  J Thromb Haemost. 2009;  7(6) 1019-1028
  CrossrefPubMedGoogle Scholar
• 8 Barry O P, Praticò D, Savani R C, FitzGerald G A. Modulation of monocyte-endothelial cell interactions by platelet microparticles.  J Clin Invest. 1998;  102(1) 136-144
  CrossrefPubMedGoogle Scholar
• 9 Mesri M, Altieri D C. Endothelial cell activation by leukocyte microparticles.  J Immunol. 1998;  161(8) 4382-4387
  PubMedGoogle Scholar
• 10 Mesri M, Altieri D C. Leukocyte microparticles stimulate endothelial cell cytokine release and tissue factor induction in a JNK1 signaling pathway.  J Biol Chem. 1999;  274(33) 23111-23118
  CrossrefPubMedGoogle Scholar
• 11 Nomura S, Tandon N N, Nakamura T, Cone J, Fukuhara S, Kambayashi J. High-shear-stress-induced activation of platelets and microparticles enhances expression of cell adhesion molecules in THP-1 and endothelial cells.  Atherosclerosis. 2001;  158(2) 277-287
  CrossrefPubMedGoogle Scholar
• 12 Curtis A M, Wilkinson P F, Gui M, Gales T L, Hu E, Edelberg J M. p38 mitogen-activated protein kinase targets the production of proinflammatory endothelial microparticles.  J Thromb Haemost. 2009;  7(4) 701-709
  CrossrefPubMedGoogle Scholar
• 13 Soleti R, Benameur T, Porro C, Panaro M A, Andriantsitohaina R, Martínez M C. Microparticles harboring Sonic Hedgehog promote angiogenesis through the upregulation of adhesion proteins and proangiogenic factors.  Carcinogenesis. 2009;  30(4) 580-588
  CrossrefPubMedGoogle Scholar
• 14 Mause S F, von Hundelshausen P, Zernecke A, Koenen R R, Weber C. Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium.  Arterioscler Thromb Vasc Biol. 2005;  25(7) 1512-1518
  CrossrefPubMedGoogle Scholar
• 15 Barry O P, Kazanietz M G, Praticò D, FitzGerald G A. Arachidonic acid in platelet microparticles up-regulates cyclooxygenase-2-dependent prostaglandin formation via a protein kinase C/mitogen-activated protein kinase-dependent pathway.  J Biol Chem. 1999;  274(11) 7545-7556
  CrossrefPubMedGoogle Scholar
• 16 Huo Y, Schober A, Forlow S B et al. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E.  Nat Med. 2003;  9(1) 61-67
  CrossrefPubMedGoogle Scholar
• 17 Gasser O, Schifferli J A. Activated polymorphonuclear neutrophils disseminate anti-inflammatory microparticles by ectocytosis.  Blood. 2004;  104(8) 2543-2548
  CrossrefPubMedGoogle Scholar
• 18 Dalli J, Norling L V, Renshaw D, Cooper D, Leung K Y, Perretti M. Annexin 1 mediates the rapid anti-inflammatory effects of neutrophil-derived microparticles.  Blood. 2008;  112(6) 2512-2519
  CrossrefPubMedGoogle Scholar
• 19 Leroyer A S, Isobe H, Lesèche G et al. Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques.  J Am Coll Cardiol. 2007;  49(7) 772-777
  CrossrefPubMedGoogle Scholar
• 20 Mallat Z, Hugel B, Ohan J, Lesèche G, Freyssinet J M, Tedgui A. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity.  Circulation. 1999;  99(3) 348-353
  CrossrefPubMedGoogle Scholar
• 21 Leroyer A S, Rautou P E, Silvestre J S et al. CD40 ligand + microparticles from human atherosclerotic plaques stimulate endothelial proliferation and angiogenesis a potential mechanism for intraplaque neovascularization.  J Am Coll Cardiol. 2008;  52(16) 1302-1311
  CrossrefPubMedGoogle Scholar
• 22 Mayr M, Grainger D, Mayr U et al. Proteomics, metabolomics, and immunomics on microparticles derived from human atherosclerotic plaques.  Circ Cardiovasc Genet. 2009;  2(4) 379-388
  CrossrefPubMedGoogle Scholar
• 23 Angelot F, Seillès E, Biichlé S et al. Endothelial cell-derived microparticles induce plasmacytoid dendritic cell maturation: potential implications in inflammatory diseases.  Haematologica. 2009;  94(11) 1502-1512
  CrossrefPubMedGoogle Scholar
• 24 Scanu A, Molnarfi N, Brandt K J, Gruaz L, Dayer J M, Burger D. Stimulated T cells generate microparticles, which mimic cellular contact activation of human monocytes: differential regulation of pro- and anti-inflammatory cytokine production by high-density lipoproteins.  J Leukoc Biol. 2008;  83(4) 921-927
  CrossrefPubMedGoogle Scholar
• 25 Canault M, Leroyer A S, Peiretti F et al. Microparticles of human atherosclerotic plaques enhance the shedding of the tumor necrosis factor-alpha converting enzyme/ADAM17 substrates, tumor necrosis factor and tumor necrosis factor receptor-1.  Am J Pathol. 2007;  171(5) 1713-1723
  CrossrefPubMedGoogle Scholar
• 26 Kim H K, Song K S, Chung J H, Lee K R, Lee S N. Platelet microparticles induce angiogenesis in vitro.  Br J Haematol. 2004;  124(3) 376-384
  CrossrefPubMedGoogle Scholar
• 27 Brill A, Dashevsky O, Rivo J, Gozal Y, Varon D. Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization.  Cardiovasc Res. 2005;  67(1) 30-38
  CrossrefPubMedGoogle Scholar
• 28 Mezentsev A, Merks R M, O'Riordan E et al. Endothelial microparticles affect angiogenesis in vitro: role of oxidative stress.  Am J Physiol Heart Circ Physiol. 2005;  289(3) H1106-H1114
  CrossrefPubMedGoogle Scholar
• 29 Yang C, Mwaikambo B R, Zhu T et al. Lymphocytic microparticles inhibit angiogenesis by stimulating oxidative stress and negatively regulating VEGF-induced pathways.  Am J Physiol Regul Integr Comp Physiol. 2008;  294(2) R467-R476
  PubMedGoogle Scholar
• 30 Leroyer A S, Ebrahimian T G, Cochain C et al. Microparticles from ischemic muscle promotes postnatal vasculogenesis.  Circulation. 2009;  119(21) 2808-2817
  CrossrefPubMedGoogle Scholar
• 31 Deregibus M C, Cantaluppi V, Calogero R et al. Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA.  Blood. 2007;  110(7) 2440-2448
  CrossrefPubMedGoogle Scholar
• 32 Taraboletti G, D'Ascenzo S, Borsotti P, Giavazzi R, Pavan A, Dolo V. Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells.  Am J Pathol. 2002;  160(2) 673-680
  CrossrefPubMedGoogle Scholar
• 33 Lacroix R, Sabatier F, Mialhe A et al. Activation of plasminogen into plasmin at the surface of endothelial microparticles: a mechanism that modulates angiogenic properties of endothelial progenitor cells in vitro.  Blood. 2007;  110(7) 2432-2439
  CrossrefPubMedGoogle Scholar
• 34 Biró E, Sturk-Maquelin K N, Vogel G M et al. Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner.  J Thromb Haemost. 2003;  1(12) 2561-2568
  CrossrefPubMedGoogle Scholar
• 35 Chou J, Mackman N, Merrill-Skoloff G, Pedersen B, Furie B C, Furie B. Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation.  Blood. 2004;  104(10) 3190-3197
  CrossrefPubMedGoogle Scholar
• 36 Nieuwland R, Berckmans R J, Rotteveel-Eijkman R C et al. Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant.  Circulation. 1997;  96(10) 3534-3541
  CrossrefPubMedGoogle Scholar
• 37 Westerberg M, Gäbel J, Bengtsson A, Sellgren J, Eidem O, Jeppsson A. Hemodynamic effects of cardiotomy suction blood.  J Thorac Cardiovasc Surg. 2006;  131(6) 1352-1357
  CrossrefPubMedGoogle Scholar
• 38 Antoniak S, Boltzen U, Eisenreich A et al. Regulation of cardiomyocyte full-length tissue factor expression and microparticle release under inflammatory conditions in vitro.  J Thromb Haemost. 2009;  7(5) 871-878
  CrossrefPubMedGoogle Scholar
• 39 Boulanger C M, Scoazec A, Ebrahimian T et al. Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction.  Circulation. 2001;  104(22) 2649-2652
  CrossrefPubMedGoogle Scholar
• 40 Vanwijk M J, Svedas E, Boer K, Nieuwland R, Vanbavel E, Kublickiene K R. Isolated microparticles, but not whole plasma, from women with preeclampsia impair endothelium-dependent relaxation in isolated myometrial arteries from healthy pregnant women.  Am J Obstet Gynecol. 2002;  187(6) 1686-1693
  CrossrefPubMedGoogle Scholar
• 41 Amabile N, Guérin A P, Leroyer A et al. Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure.  J Am Soc Nephrol. 2005;  16(11) 3381-3388
  CrossrefPubMedGoogle Scholar
• 42 Agouni A, Lagrue-Lak-Hal A H, Ducluzeau P H et al. Endothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome.  Am J Pathol. 2008;  173(4) 1210-1219
  CrossrefPubMedGoogle Scholar
• 43 Fontaine D, Pradier O, Hacquebard M et al. Oxidative stress produced by circulating microparticles in on-pump but not in off-pump coronary surgery.  Acta Cardiol. 2009;  64(6) 715-722
  CrossrefPubMedGoogle Scholar
• 44 Essayagh S, Brisset A C, Terrisse A D et al. Microparticles from apoptotic vascular smooth muscle cells induce endothelial dysfunction, a phenomenon prevented by beta3-integrin antagonists.  Thromb Haemost. 2005;  94(4) 853-858
  PubMedGoogle Scholar
• 45 Brodsky S V, Zhang F, Nasjletti A, Goligorsky M S. Endothelium-derived microparticles impair endothelial function in vitro.  Am J Physiol Heart Circ Physiol. 2004;  286(5) H1910-H1915
  CrossrefPubMedGoogle Scholar
• 46 Martin S, Tesse A, Hugel B et al. Shed membrane particles from T lymphocytes impair endothelial function and regulate endothelial protein expression.  Circulation. 2004;  109(13) 1653-1672
  CrossrefPubMedGoogle Scholar
• 47 Fontaine D, Pradier O, Hacquebard M et al. Oxidative stress produced by circulating microparticles in on-pump but not in off-pump coronary surgery.  Acta Cardiol. 2009;  64(6) 715-722
  CrossrefPubMedGoogle Scholar
• 48 Agouni A, Mostefai H A, Porro C et al. Sonic hedgehog carried by microparticles corrects endothelial injury through nitric oxide release.  FASEB J. 2007;  21(11) 2735-2741
  CrossrefPubMedGoogle Scholar
• 49 Tesse A, Martínez M C, Hugel B et al. Upregulation of proinflammatory proteins through NF-kappaB pathway by shed membrane microparticles results in vascular hyporeactivity.  Arterioscler Thromb Vasc Biol. 2005;  25(12) 2522-2527
  CrossrefPubMedGoogle Scholar
• 50 Mostefai H A, Meziani F, Mastronardi M L et al. Circulating microparticles from patients with septic shock exert protective role in vascular function.  Am J Respir Crit Care Med. 2008;  178(11) 1148-1155
  CrossrefPubMedGoogle Scholar
• 51 Pfister S L. Role of platelet microparticles in the production of thromboxane by rabbit pulmonary artery.  Hypertension. 2004;  43(2) 428-433
  CrossrefPubMedGoogle Scholar
• 52 Dasgupta S K, Abdel-Monem H, Niravath P et al. Lactadherin and clearance of platelet-derived microvesicles.  Blood. 2009;  113(6) 1332-1339
  CrossrefPubMedGoogle Scholar
• 53 Willekens F L, Werre J M, Kruijt J K et al. Liver Kupffer cells rapidly remove red blood cell-derived vesicles from the circulation by scavenger receptors.  Blood. 2005;  105(5) 2141-2145
  CrossrefPubMedGoogle Scholar
• 54 Ait-Oufella H, Kinugawa K, Zoll J et al. Lactadherin deficiency leads to apoptotic cell accumulation and accelerated atherosclerosis in mice.  Circulation. 2007;  115(16) 2168-2177
  CrossrefPubMedGoogle Scholar
• 55 Chironi G, Simon A, Hugel B et al. Circulating leukocyte-derived microparticles predict subclinical atherosclerosis burden in asymptomatic subjects.  Arterioscler Thromb Vasc Biol. 2006;  26(12) 2775-2780
  CrossrefPubMedGoogle Scholar
• 56 Heiss C, Amabile N, Lee A C et al. Brief secondhand smoke exposure depresses endothelial progenitor cells activity and endothelial function: sustained vascular injury and blunted nitric oxide production.  J Am Coll Cardiol. 2008;  51(18) 1760-1771
  CrossrefPubMedGoogle Scholar
• 57 Kagawa H, Nomura S, Nagahama M, Ozaki Y, Fukuhara S. Effect of ticlopidine on platelet-derived microparticles in patients with connective tissue diseases.  Haemostasis. 1999;  29(5) 255-261
  PubMedGoogle Scholar
• 58 Shouzu A, Nomura S, Omoto S, Hayakawa T, Nishikawa M, Iwasaka T. Effect of ticlopidine on monocyte-derived microparticles and activated platelet markers in diabetes mellitus.  Clin Appl Thromb Hemost. 2004;  10(2) 167-173
  CrossrefPubMedGoogle Scholar
• 59 Goto S, Tamura N, Li M et al. Different effects of various anti-GPIIb-IIIa agents on shear-induced platelet activation and expression of procoagulant activity.  J Thromb Haemost. 2003;  1(9) 2022-2030
  CrossrefPubMedGoogle Scholar
• 60 Morel O, Hugel B, Jesel L et al. Circulating procoagulant microparticles and soluble GPV in myocardial infarction treated by primary percutaneous transluminal coronary angioplasty. A possible role for GPIIb-IIIa antagonists.  J Thromb Haemost. 2004;  2(7) 1118-1126
  CrossrefPubMedGoogle Scholar
• 61 Rössig L, Hoffmann J, Hugel B et al. Vitamin C inhibits endothelial cell apoptosis in congestive heart failure.  Circulation. 2001;  104(18) 2182-2187
  CrossrefPubMedGoogle Scholar
• 62 Morel O, Jesel L, Hugel B et al. Protective effects of vitamin C on endothelium damage and platelet activation during myocardial infarction in patients with sustained generation of circulating microparticles.  J Thromb Haemost. 2003;  1(1) 171-177
  CrossrefPubMedGoogle Scholar
• 63 Sapet C, Simoncini S, Loriod B et al. Thrombin-induced endothelial microparticle generation: identification of a novel pathway involving ROCK-II activation by caspase-2.  Blood. 2006;  108(6) 1868-1876
  CrossrefPubMedGoogle Scholar
• 64 Tramontano A F, O'Leary J, Black A D, Muniyappa R, Cutaia M V, El-Sherif N. Statin decreases endothelial microparticle release from human coronary artery endothelial cells: implication for the Rho-kinase pathway.  Biochem Biophys Res Commun. 2004;  320(1) 34-38
  CrossrefPubMedGoogle Scholar
• 65 Diamant M, Tushuizen M E, Abid-Hussein M N et al. Simvastatin-induced endothelial cell detachment and microparticle release are prenylation dependent.  Thromb Haemost. 2008;  100(3) 489-497
  PubMedGoogle Scholar
• 66 Nomura S, Shouzu A, Omoto S, Nishikawa M, Iwasaka T. Effects of losartan and simvastatin on monocyte-derived microparticles in hypertensive patients with and without type 2 diabetes mellitus.  Clin Appl Thromb Hemost. 2004;  10(2) 133-141
  CrossrefPubMedGoogle Scholar
• 67 Nomura S, Inami N, Shouzu A et al. The effects of pitavastatin, eicosapentaenoic acid and combined therapy on platelet-derived microparticles and adiponectin in hyperlipidemic, diabetic patients.  Platelets. 2009;  20(1) 16-22
  CrossrefPubMedGoogle Scholar
• 68 Nomura S, Shouzu A, Omoto S, Nishikawa M, Iwasaka T. Long-term treatment with nifedipine modulates procoagulant marker and C-C chemokine in hypertensive patients with type 2 diabetes mellitus.  Thromb Res. 2005;  115(4) 277-285
  CrossrefPubMedGoogle Scholar
• 69 Nomura S, Shouzu A, Omoto S, Nishikawa M, Iwasaka T. Benidipine improves oxidized LDL-dependent monocyte and endothelial dysfunction in hypertensive patients with type 2 diabetes mellitus.  J Hum Hypertens. 2005;  19(7) 551-557
  CrossrefPubMedGoogle Scholar
• 70 Boulanger C M, Amabile N, Guérin A P et al. In vivo shear stress determines circulating levels of endothelial microparticles in end-stage renal disease.  Hypertension. 2007;  49(4) 902-908
  CrossrefPubMedGoogle Scholar
• 71 Gerrits A J, Koekman C A, Yildirim C, Nieuwland R, Akkerman J W. Insulin inhibits tissue factor expression in monocytes.  J Thromb Haemost. 2009;  7(1) 198-205
  CrossrefPubMedGoogle Scholar
• 72 Shimazu T, Inami N, Satoh D et al. Effect of acarbose on platelet-derived microparticles, soluble selectins, and adiponectin in diabetic patients.  J Thromb Thrombolysis. 2009;  28(4) 429-435
  CrossrefPubMedGoogle Scholar
• 73 Simak J, Gelderman M P, Yu H, Wright V, Baird A E. Circulating endothelial microparticles in acute ischemic stroke: a link to severity, lesion volume and outcome.  J Thromb Haemost. 2006;  4(6) 1296-1302
  CrossrefPubMedGoogle Scholar
• 74 Amabile N, Heiss C, Chang V et al. Increased CD62e( + ) endothelial microparticle levels predict poor outcome in pulmonary hypertension patients.  J Heart Lung Transplant. 2009;  28(10) 1081-1086
  CrossrefPubMedGoogle Scholar
• 75 Nozaki T, Sugiyama S, Koga H et al. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease.  J Am Coll Cardiol. 2009;  54(7) 601-608
  CrossrefPubMedGoogle Scholar
• 76 Amabile N, Boulanger C M, Guérin A P, Tedgui A, London G M. Circulating endothelial microparticles: a novel biomarker for prediction of subsequent death and cardiovascular events in end-stage renal disease.  Circulation. 2009;  120 S1010
  PubMedGoogle Scholar
• 77 Diamant M, Nieuwland R, Pablo R F, Sturk A, Smit J W, Radder J K. Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus.  Circulation. 2002;  106(19) 2442-2447
  CrossrefPubMedGoogle Scholar
• 78 Sabatier F, Darmon P, Hugel B et al. Type 1 and type 2 diabetic patients display different patterns of cellular microparticles.  Diabetes. 2002;  51(9) 2840-2845
  CrossrefPubMedGoogle Scholar
• 79 Preston R A, Jy W, Jimenez J J et al. Effects of severe hypertension on endothelial and platelet microparticles.  Hypertension. 2003;  41(2) 211-217
  CrossrefPubMedGoogle Scholar
• 80 Arteaga R B, Chirinos J A, Soriano A O et al. Endothelial microparticles and platelet and leukocyte activation in patients with the metabolic syndrome.  Am J Cardiol. 2006;  98(1) 70-74
  CrossrefPubMedGoogle Scholar
• 81 Ferreira A C, Peter A A, Mendez A J et al. Postprandial hypertriglyceridemia increases circulating levels of endothelial cell microparticles.  Circulation. 2004;  110(23) 3599-3603
  CrossrefPubMedGoogle Scholar
• 82 Werner N, Wassmann S, Ahlers P, Kosiol S, Nickenig G. Circulating CD31 + /annexin V + apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease.  Arterioscler Thromb Vasc Biol. 2006;  26(1) 112-116
  CrossrefPubMedGoogle Scholar
• 83 Koga H, Sugiyama S, Kugiyama K et al. Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease.  J Am Coll Cardiol. 2005;  45(10) 1622-1630
  CrossrefPubMedGoogle Scholar
• 84 Esposito K, Ciotola M, Schisano B et al. Endothelial microparticles correlate with endothelial dysfunction in obese women.  J Clin Endocrinol Metab. 2006;  91(9) 3676-3679
  CrossrefPubMedGoogle Scholar
• 85 Jayachandran M, Litwiller R D, Owen W G et al. Characterization of blood borne microparticles as markers of premature coronary calcification in newly menopausal women.  Am J Physiol Heart Circ Physiol. 2008;  295(3) H931-H938
  CrossrefPubMedGoogle Scholar
• 86 Mallat Z, Benamer H, Hugel B et al. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes.  Circulation. 2000;  101(8) 841-843
  CrossrefPubMedGoogle Scholar
• 87 Bernal-Mizrachi L, Jy W, Jimenez J J et al. High levels of circulating endothelial microparticles in patients with acute coronary syndromes.  Am Heart J. 2003;  145(6) 962-970
  CrossrefPubMedGoogle Scholar
• 88 Jung K-H, Chu K, Lee S-T et al. Circulating endothelial microparticles as a marker of cerebrovascular disease.  Ann Neurol. 2009;  66(2) 191-199
  CrossrefPubMedGoogle Scholar
• 89 Tan K T, Tayebjee M H, Lynd C, Blann A D, Lip G Y. Platelet microparticles and soluble P selectin in peripheral artery disease: relationship to extent of disease and platelet activation markers.  Ann Med. 2005;  37(1) 61-66
  CrossrefPubMedGoogle Scholar
• 90 Nomura S, Imamura A, Okuno M et al. Platelet-derived microparticles in patients with arteriosclerosis obliterans: enhancement of high shear-induced microparticle generation by cytokines.  Thromb Res. 2000;  98(4) 257-268
  CrossrefPubMedGoogle Scholar
• 91 Garcia S, Chirinos J, Jimenez J et al. Phenotypic assessment of endothelial microparticles in patients with heart failure and after heart transplantation: switch from cell activation to apoptosis.  J Heart Lung Transplant. 2005;  24(12) 2184-2189
  CrossrefPubMedGoogle Scholar
• 92 Horigome H, Hiramatsu Y, Shigeta O, Nagasawa T, Matsui A. Overproduction of platelet microparticles in cyanotic congenital heart disease with polycythemia.  J Am Coll Cardiol. 2002;  39(6) 1072-1077
  CrossrefPubMedGoogle Scholar
• 93 Morel O, Ohlmann P, Epailly E et al. Endothelial cell activation contributes to the release of procoagulant microparticles during acute cardiac allograft rejection.  J Heart Lung Transplant. 2008;  27(1) 38-45
  CrossrefPubMedGoogle Scholar
• 94 Amabile N, Heiss C, Real W M et al. Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension.  Am J Respir Crit Care Med. 2008;  177(11) 1268-1275
  CrossrefPubMedGoogle Scholar
• 95 Bakouboula B, Morel O, Faure A et al. Procoagulant membrane microparticles correlate with the severity of pulmonary arterial hypertension.  Am J Respir Crit Care Med. 2008;  177(5) 536-543
  CrossrefPubMedGoogle Scholar
• 96 Diehl P, Nagy F, Sossong V et al. Increased levels of circulating microparticles in patients with severe aortic valve stenosis.  Thromb Haemost. 2008;  99(4) 711-719
  PubMedGoogle Scholar
• 97 Ederhy S, Di Angelantonio E, Mallat Z et al. Levels of circulating procoagulant microparticles in nonvalvular atrial fibrillation.  Am J Cardiol. 2007;  100(6) 989-994
  CrossrefPubMedGoogle Scholar
• 98 Chirinos J A, Heresi G A, Velasquez H et al. Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism.  J Am Coll Cardiol. 2005;  45(9) 1467-1471
  CrossrefPubMedGoogle Scholar
• 99 Brogan P A, Shah V, Brachet C et al. Endothelial and platelet microparticles in vasculitis of the young.  Arthritis Rheum. 2004;  50(3) 927-936
  CrossrefPubMedGoogle Scholar
• 100 Erdbruegger U, Grossheim M, Hertel B et al. Diagnostic role of endothelial microparticles in vasculitis.  Rheumatology (Oxford). 2008;  47(12) 1820-1825
  CrossrefPubMedGoogle Scholar
• 101 Sellam J, Proulle V, Jüngel A et al. Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity.  Arthritis Res Ther. 2009;  11(5) R156
  CrossrefPubMedGoogle Scholar
• 102 Combes V, Simon A C, Grau G E et al. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant.  J Clin Invest. 1999;  104(1) 93-102
  CrossrefPubMedGoogle Scholar
• 103 Dignat-George F, Camoin-Jau L, Sabatier F et al. Endothelial microparticles: a potential contribution to the thrombotic complications of the antiphospholipid syndrome.  Thromb Haemost. 2004;  91(4) 667-673
  Article in Thieme ConnectPubMedGoogle Scholar
• 104 VanWijk M J, Nieuwland R, Boer K, van der Post J A, VanBavel E, Sturk A. Microparticle subpopulations are increased in preeclampsia: possible involvement in vascular dysfunction?.  Am J Obstet Gynecol. 2002;  187(2) 450-456
  CrossrefPubMedGoogle Scholar
• 105 González-Quintero V H, Jiménez J J, Jy W et al. Elevated plasma endothelial microparticles in preeclampsia.  Am J Obstet Gynecol. 2003;  189(2) 589-593
  CrossrefPubMedGoogle Scholar

1 Both authors contributed equally to the work.

Chantal M BoulangerPh.D. 

Paris – Cardiovascular Research Center at HEGP

1 INSERM - U970, 56, rue Leblanc, 75015 Paris, France

Email: chantal.boulanger@inserm.fr